Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA's Brexit: One Staffer Moving, But Impact Still May Loom Large

09 Jan 2019

• By Derrick Gingery

Brexit effect and global business consequences concept with Union Jack, EU flag on balls and world map globe 3D illustration.

Related Content

US FDA Recognizes Eight EU Authorities, Triggers Mutual Recognition Provisions

01 Nov 2017

US FDA's China Staff Increase Takes Hold As Gottlieb Boosts Border Security

14 Aug 2017

US FDA’s Foreign Inspection Agenda: Visit The 1,000 Facilities It’s Never Seen

18 Jan 2017

New UK Drug Assessment Routes Among Latest Measures For No-Deal Brexit

04 Jan 2019

UK And EMA Could Work Together Informally After Brexit

15 Mar 2018

US FDA To Rely On Inspections From More European Countries

06 Dec 2018

No-Deal Brexit: UK Can Wave Goodbye To Savings From Parallel Imports

01 Nov 2018

UK Pharma Takes Hope From Draft Brexit Deal But Uncertainty Reigns

15 Nov 2018

Jenkins' Retirement From US FDA Was Several Years In The Making

06 Dec 2016

FDA Encourages Pediatric Master Protocols With Bayesian Approach

27 Sep 2016

FDA Posts OCI Agent In Singapore, But Other Foreign Offices Close

18 Jan 2016

Additional Topics

United Kingdom Europe United States Brexit FDA Regulation BioPharmaceutical Pink Sheet Perspectives

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.